Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Pristine but metal-rich Río Sucio (Dirty River) is dominated by Gallionella and other iron-sulfur oxidizing microbes.

Arce-Rodríguez A, Puente-Sánchez F, Avendaño R, Libby E, Rojas L, Cambronero JC, Pieper DH, Timmis KN, Chavarría M.

Extremophiles. 2017 Mar;21(2):235-243. doi: 10.1007/s00792-016-0898-7. Epub 2016 Dec 8.

PMID:
27933457
2.

Functional Status and Quality of Life in Elderly Intensive Care Unit Survivors.

Villa P, Pintado MC, Luján J, González-García N, Trascasa M, Molina R, Cambronero JA, de Pablo R.

J Am Geriatr Soc. 2016 Mar;64(3):536-42. doi: 10.1111/jgs.14031.

PMID:
27000326
3.

Efficacy and Safety of Mirabegron Add-on Therapy to Solifenacin in Incontinent Overactive Bladder Patients with an Inadequate Response to Initial 4-Week Solifenacin Monotherapy: A Randomised Double-blind Multicentre Phase 3B Study (BESIDE).

Drake MJ, Chapple C, Esen AA, Athanasiou S, Cambronero J, Mitcheson D, Herschorn S, Saleem T, Huang M, Siddiqui E, Stölzel M, Herholdt C, MacDiarmid S; BESIDE study investigators.

Eur Urol. 2016 Jul;70(1):136-145. doi: 10.1016/j.eururo.2016.02.030. Epub 2016 Mar 8.

4.

Bilateral acute cortical necrosis and severe acute pancreatitis.

Arenillas C, Villa P, Rogero S, Luján J, Velo M, Cambronero JA.

Med Intensiva. 2016 Aug-Sep;40(6):383-4. doi: 10.1016/j.medin.2015.10.006. Epub 2015 Dec 22. English, Spanish. No abstract available.

5.

How should we address the diagnosis of overactive bladder in women?

Jiménez Cidre MA, López-Fando L, Esteban M, Franco A, Arlandis S, Castro D, Prieto L, Salinas J, Gutiérrez C, Gutiérrez Baños JL, Cambronero J; Grupo de investigación en Resultados de Salud en Urología Funcional y Urodinámica.

Actas Urol Esp. 2016 Jan-Feb;40(1):29-36. doi: 10.1016/j.acuro.2015.08.007. Epub 2015 Oct 20. English, Spanish.

PMID:
26493277
6.

The efficacy and safety of mirabegron compared with solifenacin in overactive bladder patients dissatisfied with previous antimuscarinic treatment due to lack of efficacy: results of a noninferiority, randomized, phase IIIb trial.

Batista JE, Kölbl H, Herschorn S, Rechberger T, Cambronero J, Halaska M, Coppell A, Kaper M, Huang M, Siddiqui E; BEYOND study group.

Ther Adv Urol. 2015 Aug;7(4):167-79. doi: 10.1177/1756287215589250.

7.

Characteristics and outcomes of elderly patients refused to ICU.

Pintado MC, Villa P, González-García N, Luján J, Molina R, Trascasa M, López-Ramos E, Martínez C, Cambronero JA, de Pablo R.

ScientificWorldJournal. 2013 Dec 25;2013:590837. doi: 10.1155/2013/590837. eCollection 2013.

8.

Efficacy of mirabegron in patients with and without prior antimuscarinic therapy for overactive bladder: a post hoc analysis of a randomized European-Australian Phase 3 trial.

Khullar V, Cambronero J, Angulo JC, Wooning M, Blauwet MB, Dorrepaal C, Martin NE.

BMC Urol. 2013 Sep 18;13:45. doi: 10.1186/1471-2490-13-45.

9.

Validation of the Spanish version of the questionnaire «Benefit, satisfaction and willingness to continue the treatment» in patients with overactive bladder.

Jiménez MA, Cambronero J.

Actas Urol Esp. 2013 Sep;37(8):473-9. doi: 10.1016/j.acuro.2013.03.005. Epub 2013 Jun 13.

PMID:
23768500
10.

Mirabegron for the treatment of overactive bladder: a prespecified pooled efficacy analysis and pooled safety analysis of three randomised, double-blind, placebo-controlled, phase III studies.

Nitti VW, Khullar V, van Kerrebroeck P, Herschorn S, Cambronero J, Angulo JC, Blauwet MB, Dorrepaal C, Siddiqui E, Martin NE.

Int J Clin Pract. 2013 Jul;67(7):619-32. doi: 10.1111/ijcp.12194. Epub 2013 May 21.

11.

Profile of lower urinary tract symptoms in the male and their impact on quality of life.

Cambronero J, Arlandis S, Errando C, Mora AM.

Actas Urol Esp. 2013 Jul-Aug;37(7):401-7. doi: 10.1016/j.acuro.2012.11.011. Epub 2013 Feb 12. English, Spanish.

PMID:
23411069
12.

Individualized PEEP setting in subjects with ARDS: a randomized controlled pilot study.

Pintado MC, de Pablo R, Trascasa M, Milicua JM, Rogero S, Daguerre M, Cambronero JA, Arribas I, Sánchez-García M.

Respir Care. 2013 Sep;58(9):1416-23. doi: 10.4187/respcare.02068. Epub 2013 Jan 29.

13.

Efficacy and tolerability of mirabegron, a β(3)-adrenoceptor agonist, in patients with overactive bladder: results from a randomised European-Australian phase 3 trial.

Khullar V, Amarenco G, Angulo JC, Cambronero J, Høye K, Milsom I, Radziszewski P, Rechberger T, Boerrigter P, Drogendijk T, Wooning M, Chapple C.

Eur Urol. 2013 Feb;63(2):283-95. doi: 10.1016/j.eururo.2012.10.016. Epub 2012 Nov 6.

PMID:
23182126
14.

Radiologic findings of segmental testicular infarction.

Fernández-Pérez GC, Tardáguila FM, Velasco M, Rivas C, Dos Santos J, Cambronero J, Trinidad C, San Miguel P.

AJR Am J Roentgenol. 2005 May;184(5):1587-93.

PMID:
15855121
15.

Medical complications derived from lucid drug use.

Cambronero JA, Nevado E, Trascasa M.

Rev Clin Esp. 2000 Aug;200(8):432-4. Spanish. No abstract available.

PMID:
11076180
16.

Medical factors in the morbidity and mortality associated with emergency colorectal cancer surgery.

Tobaruela E, Camuñas J, Enríquez-Navascúes JM, Díez M, Ratia T, Martín A, Hernández P, Lasa I, Martín A, Cambronero JA, Granell J.

Rev Esp Enferm Dig. 1997 Jan;89(1):13-22. English, Spanish.

PMID:
9055584
17.

Adrenalectomy does not change CRF secretion induced by interleukin-1 from rat perifused hypothalami.

Cambronero JC, Rivas FJ, Borrell J, Guaza C.

Regul Pept. 1992 Oct 13;41(3):237-47.

PMID:
1438991
18.

Mutually antagonistic effects of corticosterone and prolactin on rat lymphocyte proliferation.

Sandi C, Cambronero JC, Borrell J, Guaza C.

Neuroendocrinology. 1992 Oct;56(4):574-81.

PMID:
1475015
19.
20.

Interleukin-2 induces corticotropin-releasing hormone release from superfused rat hypothalami: influence of glucocorticoids.

Cambronero JC, Rivas FJ, Borrell J, Guaza C.

Endocrinology. 1992 Aug;131(2):677-83.

PMID:
1639014
21.
22.

Interleukin-1-beta induces pituitary adrenocorticotropin secretion: evidence for glucocorticoid modulation.

Cambronero JC, Rivas FJ, Borrell J, Guaza C.

Neuroendocrinology. 1992 Jun;55(6):648-54.

PMID:
1321354
23.

Effects of HPA hormones on adapted lymphocyte responsiveness to repeated stress.

Sandi C, Cambronero JC, Borrell J, Guaza C.

Brain Res Bull. 1992 Apr;28(4):581-5.

PMID:
1319796
24.

Is the adrenal cortex a putative site for the action of interleukin-1?

Cambronero JC, Rivas FJ, Borrell J, Guaza C.

Horm Metab Res. 1992 Jan;24(1):48-9. No abstract available.

PMID:
1612559
25.

[The delivery of care in cardiorespiratory arrest at a regional hospital].

Alvarez JA, Cambronero JA, Chamorro C, Rogero S.

Med Clin (Barc). 1990 Mar 10;94(9):358-9. Spanish. No abstract available.

PMID:
2329877
26.

Glucocorticoids modulate rat hypothalamic corticotrophin-releasing factor release induced by interleukin-1.

Cambronero JC, Borrell J, Guaza C.

J Neurosci Res. 1989 Dec;24(4):470-6.

PMID:
2557456
27.

[Interactions between the immune system and the neuroendocrine system. Implications of the hypothalamo-hypophyseal-adrenal axis].

Sandi C, Castro-Alamancos MA, Cambronero JC, Bailón C, Guaza C, Borrel J.

Arch Neurobiol (Madr). 1989 Nov-Dec;52(6):277-86. Review. Spanish.

PMID:
2534566
28.

[Severe infections of the soft tissues].

Cambronero JA, Yus S, Rogero S, López J, Jiménez M.

Enferm Infecc Microbiol Clin. 1989;7 Suppl 1:16-22. Review. Spanish. No abstract available.

PMID:
2490487
29.

[Association of Marchiafava-Bignami disease with centro-pontine myelinosis and Morel's laminar sclerosis: presentation of a case].

Regadera JF, Enríquez R, Morales M, Gutiérrez M, de Lorenzo A, Cambronero JA.

Med Clin (Barc). 1984 Jan 28;82(3):117-20. Spanish. No abstract available.

PMID:
6748805
30.

[Changes of the intermediary metabolism in septic patients. I. Relation to insulin requirements].

Cambronero JA, López Martínez J, Cereijo E, Pérez Picouto F, Caparros T.

Rev Clin Esp. 1980 Oct 31;159(2):95-9. Spanish. No abstract available.

PMID:
7010469
31.

[Adult respiratory distress syndrome caused by Listeria sepsis].

Cambronero JA, Cereijo Martin Grande E, López Martínez J, Pérez Picouto F, Gómez Garcés JE, López Diez F, Caparros Fernández de Aguilar T.

Rev Clin Esp. 1980 Apr 30;157(2):127-9. Spanish. No abstract available.

PMID:
7394240
32.

[Fanconi syndrome and nephrocalcinosis: an unusual association].

Ruíz Palomo F, Cambronero JA, Hernández I, Rengel M, Casado Pérez S, Villalobos E.

Rev Clin Esp. 1978 May 31;149(4):401-4. Spanish. No abstract available.

PMID:
694116

Supplemental Content

Loading ...
Support Center